Researchers and healthcare professionals express concern over the potential impact
Phase IIb trial strongly favors safety of novel agent over DOAC, but stroke impact still unclear
Payout represents an increase of more than $1 billion over a previous settlement plan
Where medicine is all fun and games
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
All-cause mortality reductions approached 50%, including advanced cancers
ChatGPT-4, other engines all made significant errors in answering board-type questions
Some clients faced life-threatening injuries after receiving injections, said federal authorities
Research shows that human-animal interactions had benefits for mood and stress
Drug is approved in combination with fludarabine
Early-stage study showed improved response rates and survival when added to standard of care
Real-world data on empagliflozin, canagliflozin, and dapagliflozin
News and commentary from the psychiatry world
Also in TTHealthWatch: improving outcomes in large strokes
乌鸦传媒 reporters offer further insights into recently covered topics
Three physicians face crossroads in patient care
A discussion with the former CEO of the Bill & Melinda Gates Foundation
Perri Klass, MD, on vaccine milestones, evolving risks, and how public health protects kids
An examination of what's driving sexual violence against women in medicine
This newly approved testing modality brings challenges and opportunities
Unequal access threatens to worsen disparities